Report Viewer

NINDS CDE Notice of Copyright
Boston Naming Test (BNT) - 30-item version
Availability
The BNT is included in the Boston Diagnostic Examination (Third Edition).
Please visit this website for more information about the instrument: Boston Naming Test (BNT) - 30-item version
Classification
NeuroRehab Supplemental - Highly Recommended:
Recommendations for Use: Indicated for studies requiring a measure of comorbidities.
Recommended for Epilepsy and Stroke studies.
 
Supplemental - Highly Recommended:  Epilepsy and Stroke
 
Supplemental: Mitochondrial Disease (Mito)
 
Exploratory: Unruptured Cerebral Aneurysms and Subarachnoid Hemorrhage (SAH)
 
 
Short Description of Instrument
Purpose
The 30-item version of the Boston Naming Test (BNT) was designed to differentiate between Alzheimer's disease (AD) and normal subjects. This version is useful for repeated assessments of a naming task, as well as in situations where administration of the complete BNT is not practical (Mack et al., 1992).
Overview
The BNT and its short forms are tasks of visual confrontation naming, sensitive to deficits in semantic retrieval. Norms for this 30-item version were developed using a registry including normal controls, mild cognitive impairment (MCI), and AD (Jefferson et al., 2007). Items have been rank ordered in terms of their ability to be named, which is thought to be correlated with their frequency.
Time
The assessment takes approximately 10 minutes.
Other Important Notes
Spanish versions of the BNT are available (Peña-Casanova et al., 2009; Ponton et al., 1996).
Comments/Special Instructions
N/A
Scoring and Psychometric Properties
Scoring
Patients have 20 seconds to respond to each item. Each item is scored as correct, correct with semantic cues, or correct with phonemic cues. The total score is the number correct spontaneously or with semantic cues.
 
Psychometric Properties
Inter-judge and intra-judge reliability were found to be high, average of 89.1% and 97.6% respectively. Overall reliability using a matrix agreement system adjusting for chance was 91.2% (Nicholas et al., 1998).
References
Jefferson AL, Wong S, Gracer TS, Ozonoff A, Green RC, Stern RA. Geriatric performance on an abbreviated version of the Boston naming test. Appl Neuropsychol. 2007;14(3):215-23.
Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use in Alzheimer's disease. J Gerontol. 1992 May;47(3):P154-158.
 
Nicholas LE, Brookshire RH, MacLennan DL, Schumacher JG, Porrazzo SA (1988). The Boston Naming Test: Revised Administration and Scoring Procedures and Normative Information for Non-Brain-Damaged Adults. Clin Aphasiology. 1988;18:103-115.
 
Peña-Casanova J, Quiñones-Ubeda S, Gramunt-Fombuena N, Aguilar M, Casas L, Molinuevo JL, Robles A, Rodríguez D, Barquero MS, Antúnez C, Martínez-Parra C, Frank-García A, Fernández M, Molano A, Alfonso V, Sol JM, Blesa R; NEURONORMA Study Team. Spanish Multicenter Normative Studies (NEURONORMA Project): norms for Boston naming test and token test. Arch Clin Neuropsychol. 2009;24(4):343-354.
 
Pontón MO, Satz P, Herrera L, Ortiz F, Urrutia CP, Young R, D'Elia LF, Furst CJ, Namerow N. Normative data stratified by age and education for the Neuropsychological Screening Battery for Hispanics (NeSBHIS): Initial report. J Int Neuropsychol Soc. 1996;2(2):96-104.
 
Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary, 3rd ed. New York: Oxford University Press; 2006, pp. 901-915.
 
Document last updated January 2022